Literature DB >> 32005527

Corrigendum to "Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)" [Epilepsy Behav 102 (2020) 106655].

Javier Abril Jaramillo1, José Carlos Estévez María2, Juan Miguel Girón Úbeda3, Óscar Vega López4, María Elena Calzado Rivas3, Hernando Pérez Díaz5, Guillermina García Martín6, Elena Vila Herrero7, María Isabel Chamorro Muñoz6, Fernando Vázquez Gutiérrez8, Cristina de la Fuente Cañete9, Luis Redondo Verge10, Nazaret Peláez Viña2, Patricia Santágueda11, Juan Jesús Rodríguez Uranga5.   

Abstract

Entities:  

Year:  2020        PMID： 32005527     DOI： 10.1016/j.yebeh.2020.106917

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN： 1525-5050            Impact factor:   2.937


× No keyword cloud information.
  1 in total

1.  Perampanel as First Add-On Therapy in Patients with Focal-Onset Seizures in the FAME Trial: Post hoc Analyses of Efficacy and Safety Related to Maintenance Dose and Background Antiepileptic Drug Therapy.

Authors:  Ji Hyun Kim; Dong Wook Kim; Sang Kun Lee; Dae-Won Seo; Ji Woong Lee; Min Young Kim; Sang Ahm Lee
Journal:  J Epilepsy Res       Date:  2022-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.